retatrutide ly3437943 triple agonist glp-1 gip glucagon Phase 3: 28.7% Weight Loss (2026) retatrutide triple agonist glp-1 gip

Although it has a minor effect on gastric emptying time, the most common side effects are nausea and vomiting

Just a few years later, Danish pharmaceutical giant Novo Nordisk had begun work on a GLP-1 drug that would not require daily injections

This is best utilized when a caregiver or partner is administering the injection for you, as it can be difficult to pinch the skin and inject simultaneously on your own arm

Plastic Surgery: If skin sagging is severe and causes physical discomfort or significant distress, plastic surgery may be an option to remove excess skin or restore volume

Why GLP-1 users lose muscle Muscle loss during weight loss is not unique to GLP-1 medications